梅毒疫苗候选Tp0751免疫诱导抗体的鉴定
本研究在Tp0751免疫兔中构建Tp0751四聚体,鉴定免疫前后Tp0751特异性B细胞,发现免疫动物血液和脾脏中该B细胞显著扩增;克隆10株抗体,其中9株可在体外显著抑制梅毒螺旋体黏附人内皮细胞,包括结合较弱者,为Tp0751亚单位疫苗可刺激强B细胞应答提供原理验证。
要点
- Tp0751免疫兔血液和脾脏中Tp0751特异性B细胞较未免疫对照显著扩增。
- 从Tp0751四聚体结合B细胞克隆10株抗体,9株体外显著抑制梅毒螺旋体黏附人内皮细胞。
- 结果提供原理验证:Tp0751亚单位疫苗可刺激强B细胞应答并产生抑制黏附的抗体。
核心结论
- Tp0751亚单位疫苗可刺激强B细胞应答,产生能抑制梅毒螺旋体黏附内皮细胞的抗体,提供原理验证。
研究设计与样本
- 在Tp0751免疫兔中生成Tp0751四聚体,鉴定免疫前后Tp0751特异性B细胞。
- 克隆Tp0751免疫兔的10株抗体,用表位定位和结构建模评估其与Tp0751蛋白特定结构区域的结合。
- 体外检测克隆抗体对梅毒螺旋体黏附人内皮细胞的抑制作用。
主要发现
- 免疫动物血液和脾脏中Tp0751特异性B细胞较未免疫对照动物显著扩增。
- 从Tp0751四聚体结合B细胞克隆的10株抗体中,9株能显著抑制梅毒螺旋体体外黏附人内皮细胞。
- 抑制黏附的抗体中包括与Tp0751结合较弱的抗体。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The continued and increasing prevalence of syphilis worldwide highlights the need for an effective syphilis vaccine to complement public health measures. Previous work demonstrated that immunization of the rabbit animal model with vaccine candidates derived from the T. pallidum endothelial cell adhesin Tp0751 could reduce dissemination of T. pallidum to lymph nodes. In those studies, a proportion of animals exhibited complete inhibition of treponemal dissemination and others exhibited partial or no inhibition of treponemal dissemination, consistent with results expected from an outbred animal model. In the current study we further characterized the Tp0751-specific antibody response in immunized animals that showed inhibition of T. pallidum dissemination. To do this, we generated Tp0751 tetramers to identify Tp0751-specific B cells before and after immunization. Using this approach, we found a robust expansion of Tp0751-specific B cells in the blood and spleens of immunized animals compared to unimmunized control animals. Ten antibodies from Tp0751-immunized rabbits were cloned and binding to specific structural regions of the Tp0751 protein was assessed using epitope mapping assays and structural modeling. Importantly, nine out of the ten antibodies cloned from Tp0751 tetramer-binding B cells were able to significantly inhibit T. pallidum attachment to human endothelial cells in vitro, including antibodies exhibiting weaker binding to Tp0751. Combined, our results provide a proof-of-principle that Tp0751-based subunit vaccines can stimulate strong B cell responses resulting in the production of antibodies able to inhibit T. pallidum attachment to endothelial cells.
引用
- Urselli F, Gomez A, Gray MD, et al. Identification of antibodies induced by immunization with the syphilis vaccine candidate Tp0751. Vaccine. 2025. PMID: 39908783. doi:10.1016/j.vaccine.2025.126804
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。